Co-Scientist: A multi-agent AI partner to accelerate research
Co-Scientist is an AI system designed to assist in biomedical research by identifying potential drug repurposing candidates. In a recent study, it helped researchers discover a treatment for liver fibrosis that blocked a significant scarring response in lab tests. The findings suggest new avenues for gene-regulating therapies for chronic liver disease.
- ▪Co-Scientist accelerated the search for liver fibrosis treatments by identifying overlooked drug candidates.
- ▪One candidate blocked 91% of a scarring-linked response in laboratory tests.
- ▪The results were published in the journal Advanced Science.
Opening excerpt (first ~120 words) tap to expand
Uncovering repurposed medicines to fight liver fibrosisCo-Scientist helped accelerate Gary Peltz’s search for liver fibrosis treatments. The AI system highlighted overlooked drug-repurposing candidates, including one that successfully blocked 91% of a scarring-linked response in lab tests. The results, published in Advanced Science, point toward new gene-regulating approaches to treat chronic liver disease.“Co-Scientist feels like a collaborator that’s read everything available about biomedical science, with the reasoning capabilities to find the connections that we’re currently missing.”Professor Gary Peltz, Stanford University School of Medicine Read case study
Excerpt limited to ~120 words for fair-use compliance. The full article is at Google DeepMind.
Discussion
0 commentsMore from Google DeepMind
